“Huge Opportunity”: BofA Starts Coverage on Nebius with Buy Rating
Bank of America initiates coverage on Nebius with a Buy rating and $150 price target, implying 31% upside.
Already have an account? Sign in.
Bank of America initiates coverage on Nebius with a Buy rating and $150 price target, implying 31% upside.
Lantheus is in talks to be bought by Curium for about $7B. No deal yet. Stock rose. Deal would be big in nuclear medicine.
FDA approves first HDV drug Hepcludex in US after prior rejection; lowers virus, but needs monitoring for safety risks.
Uber is exploring a full acquisition of European food delivery giant Delivery Hero. The deal could boost growth but faces regulatory review in Europe and involves a high financial commitment.